We are live on ! Find out more
EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

1 hedge funds and large institutions have $765K invested in Eiger BioPharmaceuticals, Inc. in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

39% less capital invested

Capital invested by funds: $1.24M → $765K (-$479K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

EIGR Hedge Fund Activity: Q4 2024 in Review

1 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Eiger BioPharmaceuticals, Inc. (EIGR) for Q4 2024, worth a combined $765K — down 39% from $1.24M a quarter earlier.

Fund positioning in EIGR was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Eiger BioPharmaceuticals, Inc. (EIGR) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $765K of Eiger BioPharmaceuticals, Inc. stock for Q4 2024, down 39% quarter-over-quarter.
  • 0 funds opened new Eiger BioPharmaceuticals, Inc. positions in Q4 2024 and 0 closed out.

Based on aggregated 13F filings for Q4 2024.